The largest database of trusted experimental protocols

Fam13a hpa038109

Manufactured by Merck Group

The FAM13A (HPA038109) is a laboratory reagent produced by Merck Group. It is a protein-coding gene that is used in various research applications. This product provides researchers with a tool to study the function and expression of the FAM13A gene.

Automatically generated - may contain errors

2 protocols using fam13a hpa038109

1

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues and cells were homogenized and lysed in lysis buffer as previously described [19 (link)]. The protein concentration was determined by Bradford  protein assay (Bio-Rad). Equal amounts of proteins were loaded and immunoblot analysis was carried out according to standard protocol. The blots were visualized using the ECL chemiluminescence system by Amersham Imager 600 (GE healthcare) and quantified by densitometric analysis using ImageQuantTL (GE healthcare). The following antibodies were used: rabbit polyclonal antibodies against FAM13A (HPA038109; Sigma Life Science); PPARγ (2435), β-Catenin (8480), IRS1 (2382), GSK3β (12456), pGSK3βS9 (9336), SIRT1 (9475) from Cell Signaling Technology; GAPDH (60004-1-IG, Proteintech); PLIN1 (GP29; Progen Biotechnik GmbH); ATGL (10006409; Cayman Chemical); C/EBPα (sc-61, Santa Cruz); β-ACTIN (MAB1501) from Millipore.
+ Open protocol
+ Expand
2

Immunoblot analysis of adipogenic proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues and cells were homogenized and lysed in lysis buffer as previously described19 (link). The protein concentration was determined by BCA protein assay (Bio-rad). Equal amounts of proteins were loaded and immunoblot analysis was carried out according to standard protocol. The blots were visualized using the ECL chemiluminescence system by Amersham Imager 600 (GE healthcare) and quantified by densitometric analysis using ImageQuantTL (GE healthcare). The following antibodies were used: rabbit polyclonal antibodies against FAM13A (HPA038109; Sigma Life Science); PPARγ (2435), β-Catenin (8480), IRS1 (2382), GSK3β (12456), pGSK3βS9 (9336), SIRT1 (9475) from Cell Signaling Technology; GAPDH (60004–1-IG, Proteintech); PLIN1 (GP29; Progen Biotechnik GmbH); ATGL (10006409; Caymen Chemicals); C/EBPα (sc-61, Santa Cruz); β-ACTIN (MAB1501) from Millipore.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!